Auteur L. GIMENEZ

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Discussing alcohol use with the GP: a qualitative study

S. COSTE ; L. GIMENEZ ; A. COMES ; X. ABDELNOUR ; J. DUPOUY ; E. ESCOURROU | 2020
Dans BJGP Open (Vol.4, n°2, June 2020) Article : Périodique

BACKGROUND: Despite most GPs recognising their role in the early diagnosis of alcohol use disorder (AUD), only 23% of GPs routinely screen for alcohol use. One reason GPs report for not screening is their relationship with patients; questions re[...]

Plus d'info

Ajouter à la sélection

Lien externe

GPs' practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network

B. LEPINE ; M. DEBIN ; L. DASSIEU ; L. GIMENEZ ; A. PALMARO ; C. PONTE ; M. SWITAL ; M. LAPEYRE-MESTRE ; T. BLANCHON ; J. DUPOUY | 2024
Dans Therapies (Vol.79, n°6, Novembre-Décembre 2024) Article : Périodique

Introduction: France is a leading country for opioid agonist treatment providing, with a predominance of buprenorphine. General practitioners (GPs) are the main prescribers of buprenorphine, but they seem to be less involved over the last 10 yea[...]

Plus d'info

Ajouter à la sélection

Lien externe

Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network

B. LEPINE ; M. DEBIN ; L. DASSIEU ; L. GIMENEZ ; A. PALMARO ; C. PONTE ; M. SWITAL ; M. LAPEYRE-MESTRE ; T. BLANCHON ; J. DUPOUY | 2022
Dans Journal of Substance Abuse Treatment (Vol.143, December 2022) Article : Périodique

Introduction: Although opioid substitution coverage in France is high and patient care with buprenorphine is mainly managed by general practitioners (GPs), buprenorphine sales have been decreasing since 2011, suggesting that French GPs are presc[...]

Plus d'info

Ajouter à la sélection

Lien externe